top of page
Innomed Tech Ltd is developing a Foley catheter and container with Patented novel design features that reduces the risk of urinary tract infections.
On completion of development, approval of Federal Drug Administration "FDA" and Patent approvals, we will seek to divest PureFlowCath, LLC. or licence the distribution of its medical devices/technologies.
Quality management systems "QMS" is required by regulators in most countries. ISO 13485 enables an organization to consistently provide safe and effective medical devices and fulfil customer and regulatory requirements. ISO 13485 is an internationally agreed standard that sets out the requirements for a quality management system specific to the medical devices industry.
InnoMed Tech Ltd chooses third-party certification where an independent certification body audits our compliance to the standard demonstrating to stakeholders and regulatory authorities that we meet the high standards of ISO 1385.
ISO International Organization for Standardization
Future Medical Science Investments
The Company structure with Innomed Tech Ltd. allows for new subsidiary companies to be established to hold other medical devices and technologies.
The Company post public listing on a regulated stock exchange will seek out additional opportunities.
Innomed Tech Ltd has established a Luxembourg Securitisation debt note facility for EURO 90 million secured byway of Patent assets.
Innomed Tech Ltd is undergoing a regulated public listing on a designated stock exchange.
bottom of page